A naukri.com initiative
Eu-Startups
1w
12
London-based iFAST Diagnostics secures over 5.9 million to combat antimicrobial resistance globally
- London-based iFAST Diagnostics has raised over 5.9 million in seed funding.
- The funding round was led by KHP Ventures and saw participation from new investors.
- iFAST is developing a high-throughput AST system to combat antimicrobial resistance.
- The company aims to launch its technology in the UK in 2025 and expand to other markets.
Read Full Article
Like
For uninterrupted reading, download the app